Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sernaz Uzunoglu

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 11, 2021
Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?Bulent Erdogan, Osman Kostek, Muhammet Bekir Hacioglu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experienceAlper Topal, Sezin Sayın, Ali Gokyer, et al.
Journal of Cancer Research and Therapeutics|July 20, 2023
Relationship between prognostic nutritional index and neutrophil lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving regorafenibBulent Erdogan, Erkan Ozcan, Ivo Gokmen, et al.
Northern Clinics of Istanbul|July 29, 2017
Clinical features of the patient with multiple primary tumors: Single center experienceAli Gokyer, Osman Kostek, Muhammet Bekir Hacioglu, et al.
Medical Oncology (Northwood, London, England)|January 10, 2015
Single-agent bevacizumab is an effective treatment in recurrent glioblastomaIlhan Hacibekiroglu, Hilmi Kodaz, Bulent Erdogan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 28, 2015
Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancerBulent Erdogan, Esma Turkmen, Tülin Deniz Yalta, et al.
Medical Oncology (Northwood, London, England)|December 9, 2010
Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in ratsSernaz Uzunoglu, Hakan Karagol, Fulya Ozpuyan, et al.
Cancer|July 7, 2007
Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center studyIrfan Cicin, Hakan Karagol, Sernaz Uzunoglu, et al.
Journal of Plastic Surgery and Hand Surgery|May 29, 2013
Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in ratsSernaz Uzunoglu, Rusen Cosar, Irfan Cicin, et al.
Bosnian Journal of Basic Medical Sciences|July 26, 2016
Unknown primary adenocarcinomas: a single-center experienceSernaz Uzunoglu, Bulent Erdogan, Hilmi Kodaz, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 11, 2021
Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?Bulent Erdogan, Osman Kostek, Muhammet Bekir Hacioglu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experienceAlper Topal, Sezin Sayın, Ali Gokyer, et al.
Journal of Cancer Research and Therapeutics|July 20, 2023
Relationship between prognostic nutritional index and neutrophil lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving regorafenibBulent Erdogan, Erkan Ozcan, Ivo Gokmen, et al.
Northern Clinics of Istanbul|July 29, 2017
Clinical features of the patient with multiple primary tumors: Single center experienceAli Gokyer, Osman Kostek, Muhammet Bekir Hacioglu, et al.
Medical Oncology (Northwood, London, England)|January 10, 2015
Single-agent bevacizumab is an effective treatment in recurrent glioblastomaIlhan Hacibekiroglu, Hilmi Kodaz, Bulent Erdogan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 28, 2015
Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancerBulent Erdogan, Esma Turkmen, Tülin Deniz Yalta, et al.
Medical Oncology (Northwood, London, England)|December 9, 2010
Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in ratsSernaz Uzunoglu, Hakan Karagol, Fulya Ozpuyan, et al.
Cancer|July 7, 2007
Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center studyIrfan Cicin, Hakan Karagol, Sernaz Uzunoglu, et al.
Journal of Plastic Surgery and Hand Surgery|May 29, 2013
Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in ratsSernaz Uzunoglu, Rusen Cosar, Irfan Cicin, et al.
Bosnian Journal of Basic Medical Sciences|July 26, 2016
Unknown primary adenocarcinomas: a single-center experienceSernaz Uzunoglu, Bulent Erdogan, Hilmi Kodaz, et al.
Pageof 4